Camidanlumab - CISMeF

Preferred Label : Camidanlumab;

NCIt definition : A human immunoglobulin (Ig) G1 monoclonal antibody directed against the alpha subunit of the interleukin-2 receptor (IL-2R alpha or CD25). Upon administration, camidanlumab specifically targets and binds to the cell surface antigen CD25. CD25, a transmembrane receptor and tumor-associated antigen (TAA), is expressed on certain cancer cells.;

UNII : UP9K666A04;

CAS number : 921618-45-3;

NCI Metathesaurus CUI : CL1382173;

Details

Origin ID

C169821;

UMLS CUI

C5418323;

Currated CISMeF NLP mapping
- Camidanlumab [SMS substance]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients